tradingkey.logo
tradingkey.logo
Search

Aptevo Therapeutics Inc

APVO
Add to Watchlist
1.850USD
+0.040+2.21%
Close 09-22 16:00ET
2.31MMarket Cap
0.00P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+2.21%

5 Days

+8.19%

1 Month

-30.97%

6 Months

-59.43%

Year to Date

-80.38%

1 Year

-93.92%

Key Figures

1.814Open
1.890High
1.75KVolume
0.00P/E TTM
LossP/E Dynamic
--Dividend TTM
0.12%Turnover Ratio
1.810Prev. Close
1.814Low
3.27KTurnover
LossP/E Static
0.44P/B
0.00%Div Yield TTM
-185.92%ROA
10.70052wk High
0.02Volume Ratio
-24.13MNet Profit
1.25MShares
1488.0455EPS TTM
1.51Beta
-550.82%ROE
9.07252wk Low
2.21%Amplitude
180.28%Gross Margin
2.31MMarket Cap
-7.34Reward/Risk
101.89%Risk Rate
More news coming soon, stay tuned...

Aptevo Therapeutics Inc's Score

-0.06vs previous score
Forecast8.00
Financial Health6.84
Technical6.42
Valuation Dimensions9.15
Institutional Confidence3.00
Risk Assessment1.89

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
25.500Target Price
+1285.87%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy00000000
Buy11111111
Hold00000000
Sell00000000
Strong Sell00000000

Aptevo Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Sell

Moving Average

Sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-5.31/-6.02
Revenue / Forecast
--/0.00

Aptevo Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolAPVO
Number of employees37
CountryUnited States of America

Ownership

ShareholdersProportion
GSA Capital Partners LLP1.66%
Vanguard Capital Management, LLC1.08%
Geode Capital Management, L.L.C.0.89%
Vanguard Fiduciary Trust Co0.35%
Shareholder TypesProportion
Investment Advisor1.91%
Hedge Fund1.67%
Investment Advisor/Hedge Fund0.89%
Research Firm0.24%

FAQs

What is the current price of Aptevo Therapeutics Inc (APVO)?

The current price of Aptevo Therapeutics Inc (APVO) is 1.85.

What is the symbol of Aptevo Therapeutics Inc?

The ticker symbol of Aptevo Therapeutics Inc is APVO.

What is the 52-week high of Aptevo Therapeutics Inc?

The 52-week high of Aptevo Therapeutics Inc is 10.70.

What is the 52-week low of Aptevo Therapeutics Inc?

The 52-week low of Aptevo Therapeutics Inc is 1.85.

What is the market capitalization of Aptevo Therapeutics Inc?

The market capitalization of Aptevo Therapeutics Inc is 2.67M.

Is Aptevo Therapeutics Inc (APVO) currently rated as Buy, Hold, or Sell?

According to analysts, Aptevo Therapeutics Inc (APVO) has an overall rating of Buy, with a price target of 25.50.

What is the Earnings Per Share (EPS TTM) of Aptevo Therapeutics Inc (APVO)?

The Earnings Per Share (EPS TTM) of Aptevo Therapeutics Inc (APVO) is 1488.05.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.